Matches in Wikidata for { <http://www.wikidata.org/entity/Q65541095> ?p ?o ?g. }
Showing items 1 to 29 of
29
with 100 items per page.
- Q65541095 description "clinical trial" @default.
- Q65541095 description "ensayu clínicu" @default.
- Q65541095 description "klinisch onderzoek" @default.
- Q65541095 description "клінічне випробування" @default.
- Q65541095 name "Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer" @default.
- Q65541095 name "Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer" @default.
- Q65541095 type Item @default.
- Q65541095 label "Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer" @default.
- Q65541095 label "Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer" @default.
- Q65541095 prefLabel "Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer" @default.
- Q65541095 prefLabel "Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer" @default.
- Q65541095 P1132 Q65541095-7F08BC5F-6CDC-438D-B76E-1A9712C58D3E @default.
- Q65541095 P1476 Q65541095-C0043E43-2564-4E14-80C6-744DF1C54470 @default.
- Q65541095 P17 Q65541095-81B4A3E9-27CE-45E4-9AEA-A4B66ECE8229 @default.
- Q65541095 P3098 Q65541095-AC2258B7-7FB3-463F-BDB6-38D3BA003937 @default.
- Q65541095 P31 Q65541095-721B161F-233A-4987-B105-0259FB7B6DD6 @default.
- Q65541095 P580 Q65541095-8DD51E95-7AD8-4DE0-8AD2-EEDF4C7E5D49 @default.
- Q65541095 P582 Q65541095-89F73F83-E0E3-49E9-8BBF-CBF650923E04 @default.
- Q65541095 P6099 Q65541095-FD4DCD67-5131-402A-AC1F-81A40C8264A3 @default.
- Q65541095 P8363 Q65541095-A8DBE815-DC07-4807-B09E-BB05902C4E80 @default.
- Q65541095 P1132 "+622" @default.
- Q65541095 P1476 "A Randomized Phase III Trial Comparing 16 to 18 Weeks of Neoadjuvant Exemestane (25 mg Daily), Letrozole (2.5 mg), or Anastrozole (1 mg) in Postmenopausal Women With Clinical Stage II and III Estrogen Receptor Positive Breast Cancer" @default.
- Q65541095 P17 Q30 @default.
- Q65541095 P3098 "NCT00265759" @default.
- Q65541095 P31 Q30612 @default.
- Q65541095 P580 "2006-01-01T00:00:00Z" @default.
- Q65541095 P582 "2012-08-01T00:00:00Z" @default.
- Q65541095 P6099 Q42824827 @default.
- Q65541095 P8363 Q78089383 @default.